文献速递神经肿瘤

颅内脑膜瘤的WHO分级与患者年龄、肿瘤位置、肿瘤大小及瘤周水肿的差异相关

WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema.
PubMed 文献 · J Neurooncol · 2019-10-01

单中心回顾性研究纳入2007年1月至2014年3月接受手术的240例原发性颅内脑膜瘤连续患者,分析WHO分级与患者及肿瘤特征的关系。WHO II级脑膜瘤在20-40岁组较41-60岁组更常见,凸面位置更常见,肿瘤体积更大且瘤周水肿更广泛;平均随访49个月,WHO II级复发率显著高于I级。

要点

  • WHO II级脑膜瘤在20-40岁年龄组较41-60岁组更常见(卡方检验 p<0.05)。
  • 凸面脑膜瘤较其他所有位置更常被分类为WHO II级(卡方检验 p<0.01)。
  • WHO II级患者平均随访49个月复发率8.2%(4/49),高于I级的1.6%(3/186)。

核心结论

  • 在本系列中,非典型脑膜瘤与较年轻年龄、凸面位置、较大肿瘤体积及更广泛的瘤周水肿相关。

研究设计与样本

  • 单中心回顾性研究,连续纳入2007年1月至2014年3月期间接受手术的原发性颅内脑膜瘤患者240例。

主要发现

  • 240例患者中女性184例(76.7%),男性56例(23.3%);20-40岁17例(7.1%),41-60岁112例(46.7%),>60岁111例(46.3%)。
  • WHO I级189例(78.8%),WHO II级49例(20.4%),WHO III级2例(0.8%)。
  • WHO II级脑膜瘤在20-40岁组较41-60岁组更常见(卡方检验 p<0.05);凸面脑膜瘤较其他所有位置更常为WHO II级(卡方检验 p<0.01)。
  • WHO II级患者计算肿瘤体积和容积测量肿瘤体积均显著大于I级:计算体积46.3±40.5 cc vs 21.8±27.8 cc,容积测量体积45.3±38.2 cc vs 23.1±30.0 cc(t检验 p<0.01)。
  • WHO II级患者瘤周水肿范围显著更大(Wilcoxon检验 p<0.05);短期结局在不同年龄组间无差异,亦与肿瘤大小无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To analyse whether the WHO grade of intracranial meningiomas differs itself depending on patients and meningioma characteristics at diagnosis. METHODS: Single center retrospective study of a series of consecutive patients with primary intracranial meningiomas who underwent surgery between January 2007 and March 2014. Patients (age, sex, outcome) and meningioma characteristics (histological diagnosis, tumor location, WHO grading, size, extend of peritumoral edema and tumor recurrence rate) were analysed. RESULTS: Of 240 included patients, 184 (76.7%) were female and 56 (23.3%) were male. 17 patients (7.1%) were in age group 20-40 years, 112 (46.7%) in group 41-60 years and 111 (46.3%) were in age group > 60 years. 189 patients (78.8%) were diagnosed with WHO grade I, 49 (20.4%) WHO grade II and 2 (0.8%) had a WHO grade III meningioma. WHO grade II meningiomas were significantly more frequent in the age group 20-40 years compared to age group 41-60 years (chi-square p < 0.05). Convexity meningiomas were significantly more frequent classified as WHO grade II meningiomas compared to all other locations (chi-square, p < 0.01). Mean calculated tumor volume and the tumor volume determined by volumetric measurement was significantly larger in grade II meningioma patients compared to grade I (46.3 ± 40.5 cc grade II versus 21.8 ± 27.8 cc grade I and 45.3 ± 38.2 cc versus 23.1 ± 30.0 cc respectively; t test < 0.01). Extend of the peritumoral edema was significantly larger in patients with grade II meningiomas (Wilcoxon test, p < 0.05). Short term outcome did not differ between different age groups nor was it associated with tumor size. During a mean follow up of 49 months (min 3, max 144 months) recurrence rate was significantly higher in WHO grade II (4 out of 49 [8.2]%) compared to WHO grade I patients (3 out if 186, [1.6%]; Chi-square, p < 0.05). CONCLUSION: In this series atypical meningioma was associated with younger age, location on the convexity, larger tumor size and more peritumoral edema.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Ressel A, Fichte S, Brodhun M, et al. WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema. J Neurooncol. 2019. PMID: 31578671. doi:10.1007/s11060-019-03293-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。